Human Pluripotent Stem Cells in Pharmacological and Toxicological Screening: New Perspectives for Personalized Medicine

• Thomson JA , Itskovitz-EldorJ, ShapiroSS et al.: Embryonic stem cell lines derived from human blastocysts.Science282(5391) , 1145–1147 (1998).
   PubMed Web of Science ®Google Scholar
• Borstlap J , LuongMX, RookeHM et al.: International stem cell registries.In Vitro Cell Dev. Biol. Anim.46(3–4) , 242–246 (2010).
   PubMedGoogle Scholar
• McDevitt TC , PalecekSP: Innovation in the culture and derivation of pluripotent human stem cells.Curr. Opin. Biotechnol.19(5) , 527–533 (2008).
   PubMed Web of Science ®Google Scholar
• Stacey GN , CoboF, NietoA, TalaveraP, HealyL, ConchaA: The development of ‘feeder‘ cells for the preparation of clinical grade hES cell lines: challenges and solutions.J. Biotechnol.125(4) , 583–588 (2006).
   PubMed Web of Science ®Google Scholar
• Stojkovic P , LakoM, StewartR et al.: An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells.Stem Cells23(3) , 306–314 (2005).
   PubMed Web of Science ®Google Scholar
• Ludwig TE , BergendahlV, LevensteinME, YuJ, ProbascoMD, ThomsonJA: Feeder-independent culture of human embryonic stem cells.Nat. Methods3(8) , 637–646 (2006).
   PubMed Web of Science ®Google Scholar
• Li Y , PowellS, BrunetteE, LebkowskiJ, MandalamR: Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products.Biotechnol. Bioeng.91(6) , 688–698 (2005).
   PubMed Web of Science ®Google Scholar
• Rodin S , DomogatskayaA, StromS et al.: Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511.Nat. Biotechnol.28(6) , 611–615 (2010).
   PubMed Web of Science ®Google Scholar
• Ellerstrom C , StrehlR, MoyaK et al.: Derivation of a xeno-free human embryonic stem cell line.Stem Cells24(10) , 2170–2176 (2006).
   PubMed Web of Science ®Google Scholar
• Ludwig TE , LevensteinME, JonesJM et al.: Derivation of human embryonic stem cells in defined conditions.Nat. Biotechnol.24(2) , 185–187 (2006).
   PubMed Web of Science ®Google Scholar
• Skottman H , DilberMS, HovattaO: The derivation of clinical-grade human embryonic stem cell lines.FEBS Lett.580(12) , 2875–2878 (2006).
   PubMed Web of Science ®Google Scholar
• Crook JM , PeuraTT, KravetsL et al.: The generation of six clinical-grade human embryonic stem cell lines.Cell Stem Cell1(5) , 490–494 (2007).
   PubMed Web of Science ®Google Scholar
• Lin G , XuRH: Progresses and challenges in optimization of human pluripotent stem cell culture.Curr. Stem Cell Res. Ther.5(3) , 207–214 (2010).
   PubMed Web of Science ®Google Scholar
• Adewumi O , AflatoonianB, Ahrlund-RichterL et al.: Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.Nat. Biotechnol.25(7) , 803–816 (2007).
   PubMed Web of Science ®Google Scholar
• Baker DE , HarrisonNJ, MaltbyE et al.: Adaptation to culture of human embryonic stem cells and oncogenesis in vivo.Nat. Biotechnol.25(2) , 207–215 (2007).
   PubMed Web of Science ®Google Scholar
• Cowan CA , KlimanskayaI, McmahonJ et al.: Derivation of embryonic stem-cell lines from human blastocysts.N. Engl. J. Med.350(13) , 1353–1356 (2004).
   PubMed Web of Science ®Google Scholar
• Draper JS , SmithK, GokhaleP et al.: Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells.Nat. Biotechnol.22(1) , 53–54 (2004).
   PubMed Web of Science ®Google Scholar
• Rosler ES , FiskGJ, AresX et al.: Long-term culture of human embryonic stem cells in feeder-free conditions.Dev. Dyn.229(2) , 259–274 (2004).
   PubMed Web of Science ®Google Scholar
• Terstegge S , LaufenbergI, PochertJ et al.: Automated maintenance of embryonic stem cell cultures.Biotechnol. Bioeng.96(1) , 195–201 (2007).
   PubMed Web of Science ®Google Scholar
• Fernandes AM , FernandesTG, DiogoMM, Da Silva CL, Henrique D, Cabral JM: Mouse embryonic stem cell expansion in a microcarrier-based stirred culture system. J. Biotechnol.132(2) , 227–236 (2007).
   PubMed Web of Science ®Google Scholar
• Itskovitz-Eldor J , SchuldinerM, KarsentiD et al.: Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers.Mol. Med.6(2) , 88–95 (2000).
   PubMed Web of Science ®Google Scholar
• Murry CE , KellerG: Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development.Cell132(4) , 661–680 (2008).
   PubMed Web of Science ®Google Scholar
• Joannides AJ , Fiore-HericheC, BattersbyAA et al.: A scaleable and defined system for generating neural stem cells from human embryonic stem cells.Stem Cells25(3) , 731–737 (2007).
   PubMed Web of Science ®Google Scholar
• Kang SM , ChoMS, SeoH et al.: Efficient induction of oligodendrocytes from human embryonic stem cells.Stem Cells25(2) , 419–424 (2007).
   PubMed Web of Science ®Google Scholar
• Laflamme MA , ChenKY, NaumovaAV et al.: Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.Nat. Biotechnol.25(9) , 1015–1024 (2007).
   PubMed Web of Science ®Google Scholar
• D‘Amour KA , BangAG, EliazerS et al.: Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells.Nat. Biotechnol.24(11) , 1392–1401 (2006).
   PubMed Web of Science ®Google Scholar
• Keller G : Embryonic stem cell differentiation: emergence of a new era in biology and medicine.Genes Dev.19(10) , 1129–1155 (2005).
   PubMed Web of Science ®Google Scholar
• Olsen AL , StachuraDL, WeissMJ: Designer blood: creating hematopoietic lineages from embryonic stem cells.Blood107(4) , 1265–1275 (2006).
   PubMed Web of Science ®Google Scholar
• Kroon E , MartinsonLA, KadoyaK et al.: Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.Nat. Biotechnol.26(4) , 443–452 (2008).
   PubMed Web of Science ®Google Scholar
• Takahashi K , YamanakaS: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell126(4) , 663–676 (2006).
   PubMed Web of Science ®Google Scholar
• Yu J , HuK, Smuga-OttoK et al.: Human induced pluripotent stem cells free of vector and transgene sequences.Science324(5928) , 797–801 (2009).
   PubMed Web of Science ®Google Scholar
• Zaehres H , KoglerG, Arauzo-BravoMJ et al.: Induction of pluripotency in human cord blood unrestricted somatic stem cells.Exp. Hematol.38(9) , 809–818, 818.e1–2 (2010).
   PubMed Web of Science ®Google Scholar
• Sun N , PanettaNJ, GuptaDM et al.: Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells.Proc. Natl Acad. Sci. USA106(37) , 15720–15725 (2009).
   PubMed Web of Science ®Google Scholar
• Liu H , YeZ, KimY, SharkisS, JangYY: Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes.Hepatology51(5) , 1810–1819 (2010).
   PubMed Web of Science ®Google Scholar
• Aasen T , RayaA, BarreroMJ et al.: Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.Nat. Biotechnol.26(11) , 1276–1284 (2008).
   PubMed Web of Science ®Google Scholar
• Loh YH , HartungO, LiH et al.: Reprogramming of T cells from human peripheral blood.Cell Stem Cell7(1) , 15–19 (2010).
   PubMed Web of Science ®Google Scholar
• Seki T , YuasaS, OdaM et al.: Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.Cell Stem Cell7(1) , 11–14 (2010).
   PubMed Web of Science ®Google Scholar
• Staerk J , DawlatyMM, GaoQ et al.: Reprogramming of human peripheral blood cells to induced pluripotent stem cells.Cell Stem Cell7(1) , 20–24 (2010).
   PubMed Web of Science ®Google Scholar
• Buchholz DE , HikitaST, RowlandTJ et al.: Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells.Stem Cells27(10) , 2427–2434 (2009).
   PubMed Web of Science ®Google Scholar
• Kim JB , SebastianoV, WuG et al.: Oct4-induced pluripotency in adult neural stem cells.Cell136(3) , 411–419 (2009).
   PubMed Web of Science ®Google Scholar
• Heng JC , FengB, HanJ et al.: The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.Cell Stem Cell6(2) , 167–174 (2010).
   PubMed Web of Science ®Google Scholar
• Picanço-Castro V , Russo-CarbolanteE, ReisLC et al.: Pluripotent reprogramming of fibroblasts by lentiviral-mediated insertion of SOX2, C-MYC, and TCL-1A.Stem Cells Dev.20(1) , 169–180 (2010).
   PubMed Web of Science ®Google Scholar
• Takahashi K , TanabeK, OhnukiM et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Cell131(5) , 861–872 (2007).
   PubMed Web of Science ®Google Scholar
• Brambrink T , ForemanR, WelsteadGG et al.: Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.Cell Stem Cell2(2) , 151–159 (2008).
   PubMed Web of Science ®Google Scholar
• Soldner F , HockemeyerD, BeardC et al.: Parkinson‘s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.Cell136(5) , 964–977 (2009).
   PubMed Web of Science ®Google Scholar
• Stadtfeld M , NagayaM, UtikalJ, WeirG, HochedlingerK: Induced pluripotent stem cells generated without viral integration.Science322(5903) , 945–949 (2008).
   PubMed Web of Science ®Google Scholar
• Kim D , KimCH, MoonJI et al.: Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.Cell Stem Cell4(6) , 472–476 (2009).
   PubMed Web of Science ®Google Scholar
• Warren L , ManosPD, AhfeldtT et al.: Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.Cell Stem Cell7(5) , 618–630 (2010).
   PubMed Web of Science ®Google Scholar
• Okita K , NakagawaM, HyenjongH, IchisakaT, YamanakaS: Generation of mouse induced pluripotent stem cells without viral vectors.Science322(5903) , 949–953 (2008).
   PubMed Web of Science ®Google Scholar
• Kaji K , NorrbyK, PacaA, MileikovskyM, MohseniP, WoltjenK: Virus-free induction of pluripotency and subsequent excision of reprogramming factors.Nature458(7239) , 771–775 (2009).
   PubMed Web of Science ®Google Scholar
• Woltjen K , MichaelIP, MohseniP et al.: piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.Nature458(7239) , 766–770 (2009).
   PubMed Web of Science ®Google Scholar
• Yusa K , RadR, TakedaJ et al.: Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon.Nat. Methods6(5) , 363–369 (2009).
   PubMed Web of Science ®Google Scholar
• Lyssiotis CA , ForemanRK, StaerkJ et al.: Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.Proc. Natl Acad. Sci. USA106(22) , 8912–8917 (2009).
   PubMed Web of Science ®Google Scholar
• Zhu S , LiW, ZhouH et al.: Reprogramming of human primary somatic cells by OCT4 and chemical compounds.Cell Stem Cell7(6) , 651–655 (2010).
   PubMed Web of Science ®Google Scholar
• Hanna J , WernigM, MarkoulakiS et al.: Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.Science318(5858) , 1920–1923 (2007).
   PubMed Web of Science ®Google Scholar
• Raya A , Rodriguez-PizaI, GuenecheaG et al.: Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.Nature460(7251) , 53–59 (2009).
   PubMed Web of Science ®Google Scholar
• Wernig M , ZhaoJP, PruszakJ et al.: Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson‘s disease.Proc. Natl Acad. Sci. USA105(15) , 5856–5861 (2008).
   PubMed Web of Science ®Google Scholar
• Carvajal-Vergara X , SevillaA, D‘SouzaSL et al.: Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.Nature465(7299) , 808–812 (2010).
   PubMed Web of Science ®Google Scholar
• Lee G , PapapetrouEP, KimH et al.: Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.Nature461(7262) , 402–406 (2009).
   PubMed Web of Science ®Google Scholar
• Ruiz JC : Generation of adipose stromal cell-derived hepatic cells.Methods Mol. Biol.702 , 249–260 (2010).
   Google Scholar
• Szabo E , RampalliS, RisuenoRM et al.: Direct conversion of human fibroblasts to multilineage blood progenitors.Nature468(7323) , 521–526 (2010).
   PubMed Web of Science ®Google Scholar
• Vierbuchen T , OstermeierA, PangZP, KokubuY, SudhofTC, WernigM: Direct conversion of fibroblasts to functional neurons by defined factors.Nature463(7284) , 1035–1041 (2010).
   PubMed Web of Science ®Google Scholar
• Ieda M , FuJD, Delgado-OlguinP et al.: Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.Cell142(3) , 375–386 (2010).
   PubMed Web of Science ®Google Scholar
• Xu Y , ZhuX, HahmHS et al.: Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules.Proc. Natl Acad. Sci. USA107(18) , 8129–8134 (2010).
   PubMed Web of Science ®Google Scholar
• Cabaniols JP , MathisL, DelendaC: Targeted gene modifications in drug discovery and development.Curr. Opin. Pharmacol.9(5) , 657–663 (2009).
   PubMed Web of Science ®Google Scholar
• Frecha C , SzecsiJ, CossetFL, VerhoeyenE: Strategies for targeting lentiviral vectors.Curr. Gene Ther.8(6) , 449–460 (2008).
   PubMed Web of Science ®Google Scholar
• Qasim W , VinkCA, ThrasherAJ: Hybrid lentiviral vectors.Mol. Ther.18(7) , 1263–1267 (2010).
   PubMed Web of Science ®Google Scholar
• Dissen GA , LomnicziA, NeffTL et al.: In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles.Methods49(1) , 70–77 (2009).
   PubMed Web of Science ®Google Scholar
• Garcia-Perez JL , MorellM, ScheysJO et al.: Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells.Nature466(7307) , 769–773 (2010).
   PubMed Web of Science ®Google Scholar
• Matsui T , LeungD, MiyashitaH et al.: Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET.Nature464(7290) , 927–931 (2010).
   PubMed Web of Science ®Google Scholar
• Ivics Z , HackettPB, PlasterkRH, IzsvakZ: Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells.Cell91(4) , 501–510 (1997).
   PubMed Web of Science ®Google Scholar
• Miskey C , IzsvakZ, PlasterkRH, IvicsZ: The Frog Prince: a reconstructed transposon from Rana pipiens with high transpositional activity in vertebrate cells.Nucleic Acids Res.31(23) , 6873–6881 (2003).
   PubMed Web of Science ®Google Scholar
• Ding S , WuX, LiG, HanM, ZhuangY, XuT: Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice.Cell122(3) , 473–483 (2005).
   PubMed Web of Science ®Google Scholar
• Balciunas D , WangensteenKJ, WilberA et al.: Harnessing a high cargo-capacity transposon for genetic applications in vertebrates.PLoS Genet.2(11) , e169 (2006).
   PubMed Web of Science ®Google Scholar
• Cadinanos J , BradleyA: Generation of an inducible and optimized piggyBac transposon system.Nucleic Acids Res.35(12) , e87 (2007).
   PubMed Web of Science ®Google Scholar
• Mates L , ChuahMK, BelayE et al.: Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.Nat. Genet.41(6) , 753–761 (2009).
   PubMed Web of Science ®Google Scholar
• Izsvak Z , HackettPB, CooperLJ, IvicsZ: Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.Bioessays32(9) , 756–767 (2010).
   PubMed Web of Science ®Google Scholar
• Grabundzija I , IrgangM, MatesL et al.: Comparative analysis of transposable element vector systems in human cells.Mol. Ther.18(6) , 1200–1209 (2010).
   PubMed Web of Science ®Google Scholar
• Liu G , GeurtsAM, YaeK et al.: Target-site preferences of Sleeping Beauty transposons.J. Mol. Biol.346(1) , 161–173 (2005).
   PubMed Web of Science ®Google Scholar
• Williams DA : Sleeping beauty vector system moves toward human trials in the United States.Mol. Ther.16(9) , 1515–1516 (2008).
   PubMed Web of Science ®Google Scholar
• Chen YT , FurushimaK, HouPS et al.: PiggyBac transposon-mediated, reversible gene transfer in human embryonic stem cells.Stem Cells Dev.19(6) , 763–771 (2010).
   PubMed Web of Science ®Google Scholar
• Orban TI , ApatiA, NemethA et al.: Applying a “double-feature” promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.Stem Cells27(5) , 1077–1087 (2009).
   PubMed Web of Science ®Google Scholar
• Wang W , LinC, LuD et al.: Chromosomal transposition of PiggyBac in mouse embryonic stem cells.Proc. Natl Acad. Sci. USA105(27) , 9290–9295 (2008).
   PubMed Web of Science ®Google Scholar
• Wilber A , LinehanJL, TianX et al.: Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer.Stem Cells25(11) , 2919–2927 (2007).
   PubMed Web of Science ®Google Scholar
• Bowers WJ , MastrangeloMA, HowardDF, SoutherlandHA, Maguire-ZeissKA, FederoffHJ: Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector.Mol. Ther.13(3) , 580–588 (2006).
   PubMed Web of Science ®Google Scholar
• De Silva S , MastrangeloMA, LottaLT Jr et al.: Extending the transposable payload limit of Sleeping Beauty (SB) using the herpes simplex virus (HSV)/SB amplicon-vector platform. Gene Ther.17(3) , 424–431 (2010).
   PubMed Web of Science ®Google Scholar
• Staunstrup NH , MoldtB, MatesL et al.: Hybrid lentivirus-transposon vectors with a random integration profile in human cells.Mol. Ther.17(7) , 1205–1214 (2009).
   PubMed Web of Science ®Google Scholar
• Vink CA , GasparHB, GabrielR et al.: Sleeping beauty transposition from nonintegrating lentivirus.Mol. Ther.17(7) , 1197–1204 (2009).
   PubMed Web of Science ®Google Scholar
• Ivics Z , KatzerA, StuweEE, FiedlerD, KnespelS, IzsvakZ: Targeted Sleeping Beauty transposition in human cells.Mol. Ther.15(6) , 1137–1144 (2007).
   PubMed Web of Science ®Google Scholar
• Cabaniols JP , PaquesF: Robust cell line development using meganucleases.Methods Mol. Biol.435 , 31–45 (2008).
   PubMedGoogle Scholar
• Redondo P , PrietoJ, MunozIG et al.: Molecular basis of Xeroderma pigmentosum group C DNA recognition by engineered meganucleases.Nature456(7218) , 107–111 (2008).
   PubMed Web of Science ®Google Scholar
• Fougerousse F , BullenP, HerasseM et al.: Human-mouse differences in the embryonic expression patterns of developmental control genes and disease genes.Hum. Mol. Genet.9(2) , 165–173 (2000).
   PubMed Web of Science ®Google Scholar
• Freeze HH : Human disorders in N-glycosylation and animal models.Biochim. Biophys. Acta1573(3) , 388–393 (2002).
   PubMed Web of Science ®Google Scholar
• Grayson BE , KievitP, SmithMS, GroveKL: Critical determinants of hypothalamic appetitive neuropeptide development and expression: species considerations.Front. Neuroendocrinol.31(1) , 16–31 (2010).
   PubMed Web of Science ®Google Scholar
• Ding S , WuTY, BrinkerA et al.: Synthetic small molecules that control stem cell fate.Proc. Natl Acad. Sci. USA100(13) , 7632–7637 (2003).
   PubMed Web of Science ®Google Scholar
• Genschow E , SpielmannH, ScholzG et al.: Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests.Altern. Lab. Anim.32(3) , 209–244 (2004).
   PubMed Web of Science ®Google Scholar
• Stummann TC , HarengL, BremerS: Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells.Toxicology252(1–3) , 118–122 (2008).
   PubMed Web of Science ®Google Scholar
• Piersma AH : Alternative methods for developmental toxicity testing.Basic Clin. Pharmacol. Toxicol.98(5) , 427–431 (2006).
   PubMed Web of Science ®Google Scholar
• De Jong E , DoedeeAM, Reis-FernandesMA, NauH, PiersmaAH: Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.Reprod. Toxicol. (2010) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Pal R , MamidiMK, DasAK et al.: Human embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity.J. Cell Physiol.226(6) , 1583–1595 (2011).
   PubMed Web of Science ®Google Scholar
• Coecke S , GoldbergAM, AllenS et al.: Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies.Environ. Health Perspect.115(6) , 924–931 (2007).
   PubMed Web of Science ®Google Scholar
• Betts KS : Growing knowledge: using stem cells to study developmental neurotoxicity.Environ. Health Perspect.118(10) , A432–A437 (2010).
   PubMed Web of Science ®Google Scholar
• Bushway PJ , MercolaM: High-throughput screening for modulators of stem cell differentiation.Methods Enzymol.414 , 300–316 (2006).
   PubMed Web of Science ®Google Scholar
• Wu X , DingS, DingQ, GrayNS, SchultzPG: Small molecules that induce cardiomyogenesis in embryonic stem cells.J. Am. Chem. Soc.126(6) , 1590–1591 (2004).
   PubMed Web of Science ®Google Scholar
• Ventura C , MaioliM, AsaraY et al.: Butyric and retinoic mixed ester of hyaluronan. A novel differentiating glycoconjugate affording a high throughput of cardiogenesis in embryonic stem cells.J. Biol. Chem.279(22) , 23574–23579 (2004).
   PubMed Web of Science ®Google Scholar
• Wang Y , ChenG, SongT, MaoG, BaiH: Enhancement of cardiomyocyte differentiation from human embryonic stem cells.Sci. China Life Sci.53(5) , 581–589 (2010).
   PubMed Web of Science ®Google Scholar
• Gaur M , RitnerC, SieversR et al.: Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes.Cytotherapy12(6) , 807–817 (2010).
   PubMed Web of Science ®Google Scholar
• Moretti A , BellinM, WellingA et al.: Patient-specific induced pluripotent stem-cell models for long-QT syndrome.N. Engl. J. Med.363(15) , 1397–1409 (2010).
   PubMed Web of Science ®Google Scholar
• Itzhaki I , MaizelsL, HuberI et al.: Modelling the long QT syndrome with induced pluripotent stem cells.Nature471(7337) , 225–229 (2011).
   PubMed Web of Science ®Google Scholar
• Yazawa M , HsuehB, JiaX et al.: Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.Nature471 , 230–234 (2011).
   PubMed Web of Science ®Google Scholar
• Buzanska L , ZychowiczM, RuizA et al.: Neural stem cells from human cord blood on bioengineered surfaces – novel approach to multiparameter bio-tests.Toxicology270(1) , 35–42 (2010).
   PubMed Web of Science ®Google Scholar
• Ebert AD , SvendsenCN: Human stem cells and drug screening: opportunities and challenges.Nat. Rev. Drug Discov.9(5) , 367–372 (2010).
   PubMed Web of Science ®Google Scholar
• Gomez-Lechon MJ , LahozA, GombauL, CastellJV, DonatoMT: In vitro evaluation of potential hepatotoxicity induced by drugs.Curr. Pharm. Des.16(17) , 1963–1977 (2010).
   PubMed Web of Science ®Google Scholar
• Hewitt NJ , LechonMJ, HoustonJB et al.: Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.Drug Metab. Rev.39(1) , 159–234 (2007).
   PubMed Web of Science ®Google Scholar
• Castell JV , JoverR, Martinez-JimenezCP, Gomez-LechonMJ: Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies.Expert Opin. Drug Metab. Toxicol.2(2) , 183–212 (2006).
   PubMed Web of Science ®Google Scholar
• Baxter MA , RoweC, AlderJ et al.: Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening.Stem Cell Res.5(1) , 4–22 (2010).
   PubMed Web of Science ®Google Scholar
• Jasmund I , SchwientekS, AcikgozA, LangschA, MachensHG, BaderA: The influence of medium composition and matrix on long-term cultivation of primary porcine and human hepatocytes.Biomol. Eng.24(1) , 59–69 (2007).
   PubMedGoogle Scholar
• Kamiya A , KinoshitaT, MiyajimaA: Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways.FEBS Lett.492(1–2) , 90–94 (2001).
   PubMed Web of Science ®Google Scholar
• Kamiya A , KinoshitaT, ItoY et al.: Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.EMBO J.18(8) , 2127–2136 (1999).
   PubMed Web of Science ®Google Scholar
• Inamura M , KawabataK, TakayamaK et al.: Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox geneHEX. Mol. Ther.19(2) , 400–407 (2011).
   PubMed Web of Science ®Google Scholar
• D‘amour KA , AgulnickAD, EliazerS, KellyOG, KroonE, BaetgeEE: Efficient differentiation of human embryonic stem cells to definitive endoderm.Nat. Biotechnol.23(12) , 1534–1541 (2005).
   PubMed Web of Science ®Google Scholar
• Duan Y , CatanaA, MengY et al.: Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo.Stem Cells25(12) , 3058–3068 (2007).
   PubMed Web of Science ®Google Scholar
• Momose Y , MatsunagaT, MuraiK, TakezawaT, OhmoriS: Differentiation of monkey embryonic stem cells into hepatocytes and mRNA expression of cytochrome p450 enzymes responsible for drug metabolism: comparison of embryoid body formation conditions and matrices.Biol. Pharm. Bull.32(4) , 619–626 (2009).
   PubMed Web of Science ®Google Scholar
• Rashid ST , CorbineauS, HannanN et al.: Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.J. Clin. Invest.120(9) , 3127–3136 (2010).
   PubMed Web of Science ®Google Scholar
• Yan Y , YangD, ZarnowskaED et al.: Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.Stem Cells23(6) , 781–790 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang XQ , ZhangSC: Differentiation of neural precursors and dopaminergic neurons from human embryonic stem cells.Methods Mol. Biol.584 , 355–366 (2010).
   PubMedGoogle Scholar
• Hu BY , ZhangSC: Directed differentiation of neural-stem cells and subtype-specific neurons from hESCs.Methods Mol. Biol.636 , 123–137 (2010).
   PubMedGoogle Scholar
• Li XJ , DuZW, ZarnowskaED et al.: Specification of motoneurons from human embryonic stem cells.Nat. Biotechnol.23(2) , 215–221 (2005).
   PubMed Web of Science ®Google Scholar
• Braam SR , DenningC, van den Brink S et al.: Improved genetic manipulation of human embryonic stem cells. Nat. Methods5(5) , 389–392 (2008).
   PubMed Web of Science ®Google Scholar
• Hohenstein KA , PyleAD, ChernJY, LockLF, DonovanPJ: Nucleofection mediates high-efficiency stable gene knockdown and transgene expression in human embryonic stem cells.Stem Cells26(6) , 1436–1443 (2008).
   PubMed Web of Science ®Google Scholar
• Schneider BL , SeehusCR, CapowskiEE, AebischerP, ZhangSC, SvendsenCN: Over-expression of α-synuclein in human neural progenitors leads to specific changes in fate and differentiation.Hum. Mol. Genet.16(6) , 651–666 (2007).
   PubMed Web of Science ®Google Scholar
• Ebert AD , YuJ, RoseFF Jr et al.: Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature457(7227) , 277–280 (2009).
   PubMed Web of Science ®Google Scholar
• Laverty H , BensonC, CartwrightE et al.: How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?: Report on the Medical Research Council Centre for Drug Safety Science workshop on ‘Cardiovascular Toxicity of Medicines‘.Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2011.01255.x (2011) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Kirchhof P , BreithardtG, EckardtL: Primary prevention of sudden cardiac death.Heart92(12) , 1873–1878 (2006).
   PubMed Web of Science ®Google Scholar
• Moss AJ , KassRS: Long QT syndrome: from channels to cardiac arrhythmias.J. Clin. Invest.115(8) , 2018–2024 (2005).
   PubMed Web of Science ®Google Scholar
• Lacerda AE , KuryshevYA, ChenY et al.: Alfuzosin delays cardiac repolarization by a novel mechanism.J. Pharmacol. Exp. Ther.324(2) , 427–433 (2008).
   PubMed Web of Science ®Google Scholar
• Towart R , LindersJT, HermansAN et al.: Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?J. Pharmacol. Toxicol. Methods60(1) , 1–10 (2009).
   PubMedGoogle Scholar
• Rudy Y , AckermanMJ, BersDM et al.: Systems approach to understanding electromechanical activity in the human heart: a national heart, lung, and blood institute workshop summary.Circulation118(11) , 1202–1211 (2008).
   PubMed Web of Science ®Google Scholar
• Mummery C , Ward-van Oostwaard D, Doevendans P et al.: Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation107(21) , 2733–2740 (2003).
   PubMed Web of Science ®Google Scholar
• Xu C , PoliceS, RaoN et al.: Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells.Circ. Res.91(6) , 501–508 (2002).
   PubMed Web of Science ®Google Scholar
• Yang L , SoonpaaMH, AdlerED, CarpenterMK: Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population.Nature453(7194) , 524–528 (2008).
   PubMed Web of Science ®Google Scholar
• Gadue P , HuberTL, PaddisonPJ, KellerGM: Wnt and TGF-β signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells.Proc. Natl Acad. Sci. USA103(45) , 16806–16811 (2006).
   PubMed Web of Science ®Google Scholar
• Lindsley RC , GillJG, KybaM, MurphyTL, MurphyKM: Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm.Development133(19) , 3787–3796 (2006).
   PubMed Web of Science ®Google Scholar
• Kattman SJ , WittyAD, GagliardiM et al.: Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.Cell Stem Cell8(2) , 228–240 (2011).
   PubMed Web of Science ®Google Scholar
• Chen VC , StullR, JooD, ChengX, KellerG: Notch signaling respecifies the hemangioblast to a cardiac fate.Nat. Biotechnol.26(10) , 1169–1178 (2008).
   PubMed Web of Science ®Google Scholar
• Martinez-Fernandez A , NelsonTJ, IkedaY, TerzicA: c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.J. Cardiovasc. Transl. Res.3(1) , 13–23 (2010).
   PubMed Web of Science ®Google Scholar
• Bu L , JiangX, Martin-PuigS et al.: Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages.Nature460(7251) , 113–117 (2009).
   PubMed Web of Science ®Google Scholar
• Moretti A , BellinM, JungCB et al.: Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors.FASEB J.24(3) , 700–711 (2010).
   PubMed Web of Science ®Google Scholar
• Gupta MK , IllichDJ, GaarzA et al.: Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar.BMC Dev. Biol.10 , 98 (2010).
   PubMed Web of Science ®Google Scholar
• He JQ , MaY, LeeY, ThomsonJA, KampTJ: Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization.Circ. Res.93(1) , 32–39 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang J , WilsonGF, SoerensAG et al.: Functional cardiomyocytes derived from human induced pluripotent stem cells.Circ. Res.104(4) , e30–e41 (2009).
   PubMed Web of Science ®Google Scholar
• Sartiani L , BettiolE, StillitanoF, MugelliA, CerbaiE, JaconiME: Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.Stem Cells25(5) , 1136–1144 (2007).
   PubMed Web of Science ®Google Scholar
• Satin J , KehatI, CaspiO et al.: Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes.J. Physiol.559(Pt 2) , 479–496 (2004).
   PubMed Web of Science ®Google Scholar
• Binah O , DolnikovK, SadanO et al.: Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes.J. Electrocardiol.40(Suppl. 6) , S192–S196 (2007).
   PubMed Web of Science ®Google Scholar
• Brito-Martins M , HardingSE, AliNN: β(1)- and β(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart.Br. J. Pharmacol.153(4) , 751–759 (2008).
   PubMed Web of Science ®Google Scholar
• Dolnikov K , ShilkrutM, Zeevi-LevinN et al.: Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction.Stem Cells24(2) , 236–245 (2006).
   PubMed Web of Science ®Google Scholar
• Germanguz I , SedanO, Zeevi-LevinN et al.: Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells.J. Cell Mol. Med.15(1) , 38–51 (2011).
   PubMed Web of Science ®Google Scholar
• Anderson D , SelfT, MellorIR, GohG, HillSJ, DenningC: Transgenic enrichment of cardiomyocytes from human embryonic stem cells.Mol. Ther.15(11) , 2027–2036 (2007).
   PubMed Web of Science ®Google Scholar
• Huber I , ItzhakiI, CaspiO et al.: Identification and selection of cardiomyocytes during human embryonic stem cell differentiation.FASEB J.21(10) , 2551–2563 (2007).
   PubMed Web of Science ®Google Scholar
• Kita-Matsuo H , BarcovaM, PrigozhinaN et al.: Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes.PLoS ONE4(4) , e5046 (2009).
   PubMed Web of Science ®Google Scholar
• Xu XQ , ZweigerdtR, SooSY et al.: Highly enriched cardiomyocytes from human embryonic stem cells.Cytotherapy10(4) , 376–389 (2008).
   PubMed Web of Science ®Google Scholar
• Hattori F , ChenH, YamashitaH et al.: Nongenetic method for purifying stem cell-derived cardiomyocytes.Nat. Methods7(1) , 61–66 (2010).
   PubMed Web of Science ®Google Scholar
• Rust W , BalakrishnanT, ZweigerdtR: Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression.Reg. Med.4(2) , 225–237 (2009).
   PubMed Web of Science ®Google Scholar
• Van Hoof D , DormeyerW, BraamSR et al.: Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes.J. Proteome Res.9(3) , 1610–1618 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang Q , JiangJ, HanP et al.: Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals.Cell Res.21(4) , 579–587 (2011).
   PubMed Web of Science ®Google Scholar
• Zhu WZ , XieY, MoyesKW, GoldJD, AskariB, LaflammeMA: Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells.Circ. Res.107(6) , 776–786 (2010).
   PubMed Web of Science ®Google Scholar
• Jonsson MK , DukerG, TroppC et al.: Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes.Stem Cell Res.4(3) , 189–200 (2010).
   PubMed Web of Science ®Google Scholar
• Fu JD , JiangP, RushingS, LiuJ, ChiamvimonvatN, LiRA: Na+/Ca2+ exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes.Stem Cells Dev.19(6) , 773–782 (2010).
   PubMed Web of Science ®Google Scholar
• Harding SE , AliNN, Brito-MartinsM, GorelikJ: The human embryonic stem cell-derived cardiomyocyte as a pharmacological model.Pharmacol. Ther.113(2) , 341–353 (2007).
   PubMed Web of Science ®Google Scholar
• Peng S , LacerdaAE, KirschGE, BrownAM, Bruening-WrightA: The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes.J. Pharmacol. Toxicol. Methods61(3) , 277–286 (2010).
   PubMed Web of Science ®Google Scholar
• Caspi O , ItzhakiI, KehatI et al.: In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes.Stem Cells Dev.18(1) , 161–172 (2009).
   PubMed Web of Science ®Google Scholar
• Gai H , LeungEL, CostantinoPD et al.: Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts.Cell Biol. Int.33(11) , 1184–1193 (2009).
   PubMed Web of Science ®Google Scholar
• Tanaka T , TohyamaS, MurataM et al.: In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes.Biochem. Biophys. Res. Commun.385(4) , 497–502 (2009).
   PubMed Web of Science ®Google Scholar
• Yokoo N , BabaS, KaichiS et al.: The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells.Biochem. Biophys. Res. Commun.387(3) , 482–488 (2009).
   PubMed Web of Science ®Google Scholar
• Braam SR , TertoolenL, Van De Stolpe A, Meyer T, Passier R, Mummery CL: Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res.4(2) , 107–116 (2010).
   PubMed Web of Science ®Google Scholar
• Asai Y , TadaM, OtsujiTG, NakatsujiN: Combination of functional cardiomyocytes derived from human stem cells and a highly-efficient microelectrode array system: an ideal hybrid model assay for drug development.Curr. Stem Cell Res. Ther.5(3) , 227–232 (2010).
   PubMed Web of Science ®Google Scholar
• Andersson H , SteelD, AspJ et al.: Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells.J. Biotechnol.150(1) , 175–181 (2010).
   PubMed Web of Science ®Google Scholar
• Koseki N , DeguchiJ, YamadaT, FunabashiH, SekiT: Usefulness of field potential as a marker of embryonic stem cell-derived cardiomyocytes, and endpoint analysis of embryonic stem cell test.J. Toxicol. Sci.35(6) , 899–909 (2010).
   PubMed Web of Science ®Google Scholar
• Kim MJ , LeeSC, PalS, HanE, SongJM: High-content screening of drug-induced cardiotoxicity using quantitative single cell imaging cytometry on microfluidic device.Lab. Chip11(1) , 104–114 (2010).
   PubMed Web of Science ®Google Scholar
• Stevens KR , PabonL, MuskheliV, MurryCE: Scaffold-free human cardiac tissue patch created from embryonic stem cells.Tissue Eng. Part A15(6) , 1211–1222 (2009).
   PubMed Web of Science ®Google Scholar
• Hansen A , EderA, BonstrupM et al.: Development of a drug screening platform based on engineered heart tissue.Circ. Res.107(1) , 35–44 (2010).
   PubMed Web of Science ®Google Scholar
• Musunuru K , DomianIJ, ChienKR: Stem cell models of cardiac development and disease.Annu. Rev. Cell Dev. Biol.26 , 667–687 (2010).
   PubMed Web of Science ®Google Scholar
• Fabritz L , KirchhofP: Predictable and less predictable unwanted cardiac drugs effects: individual pre-disposition and transient precipitating factors.Basic Clin. Pharmacol. Toxicol.106(3) , 263–268 (2010).
   PubMed Web of Science ®Google Scholar

▪ Websites

• ChanTest® safety services www.chantest.com/safety-services
   Google Scholar
• QTempo www.reprocell.net/Shop/Drug-Discovery-AND-Development/Human-iPS-cell-derived-Cardiomyocyte/964-QTempo.html
   Google Scholar
• Cytiva cardiomyocytes www.gelifesciences.com/aptrix/upp01077.nsf/Content/Products?OpenDocument&parentid=1036322&moduleid=167991
   Google Scholar
• Cardiomyocyte monolayers www.cellartis.com/products/differentiated-cells/cardiomyocyte-monolayers
   Google Scholar
• Cardiomyocyte clusters www.cellartis.com/products/differentiated-cells/cardiomyocyte-clusters
   Google Scholar
• iCell® cardiomyocytes www.cellulardynamics.com/products/cardiomyocytes.html
   Google Scholar
• ReproCardio kit: human iPS cell-derived cardiomyocyte www.reprocell.net/Shop/Drug-Discovery-AND-Development/Human-iPS-cell-derived-Cardiomyocyte/989-ReproCardio-kit.html
   Google Scholar
• Hepatocyte-like cells www.cellartis.com/products/differentiated-cells/hepatocyte-like-cells
   Google Scholar
• Cellular dynamics product pipeline www.cellulardynamics.com/tech/pipeline.html
   Google Scholar
• MotorPlate™ human ESC-derived motor neuron progenitors www.lonzabio.com/cell-biology/pluripotent-stem-cell-products/hpsc-derived-cell-types/
   Google Scholar
• ReproNeuro DA kit www.reprocell.net/Shop/Drug-Discovery-AND-Development/Human-iPS-cell-derived-Neural-Cells/1000-ReproNeuro-DA-kit.html
   Google Scholar